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Abstract
Background: Patients presenting with chest pain represent a large proportion of attendances to emergency
departments. In these patients clinicians often consider the diagnosis of acute myocardial infarction (AMI), the
timely recognition and treatment of which is clinically important. Clinical prediction models (CPMs) have been used
to enhance early diagnosis of AMI. The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision
aid is currently in clinical use across Greater Manchester. CPMs have been shown to deteriorate over time through
calibration drift. We aim to assess potential calibration drift with T-MACS and compare methods for updating the
model.
Methods: We will use routinely collected electronic data from patients who were treated using TMACS at two large
NHS hospitals. This is estimated to include approximately 14,000 patient episodes spanning June 2016 to October
2020. The primary outcome of acute myocardial infarction will be sourced from NHS Digital’s admitted patient care
dataset. We will assess the calibration drift of the existing model and the benefit of updating the CPM by model
recalibration, model extension and dynamic updating. These models will be validated by bootstrapping and one
step ahead prequential testing. We will evaluate predictive performance using calibrations plots and c-statistics. We
will also examine the reclassification of predicted probability with the updated TMACS model.
Discussion: CPMs are widely used in modern medicine, but are vulnerable to deteriorating calibration over time.
Ongoing refinement using routinely collected electronic data will inevitably be more efficient than deriving and
validating new models. In this analysis we will seek to exemplify methods for updating CPMs to protect the initial
investment of time and effort. If successful, the updating methods could be used to continually refine the
algorithm used within TMACS, maintaining or even improving predictive performance over time.
Trial registration: ISRCTN number: ISRCTN41008456
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Background
Chest pain accounts for approximately 6% of all Emer-
gency Department (ED) attendances [1]. Despite recent
advances in diagnostic technology and changes to na-
tional guidelines [2, 3], it remains the most common
reason for emergency hospital admission in England and
Wales [1]. These patients are frequently admitted to
undergo diagnostic evaluation for suspected acute cor-
onary syndrome (ACS). Improved diagnostic pathways
could allow those without an ACS diagnosis (over
100,000 patients per year in England and Wales) to be
discharged from the ED without an unnecessary hospital
admission. Equally it is integral that we try to capture as
many ACS diagnoses as we can, since a missed ACS in-
fers twice the mortality of a detected ACS [4].
The Troponin-only Manchester Acute Coronary Syn-
dromes (T-MACS) decision aid can be used to rapidly
rule in, rule out and risk stratify patients with suspected
ACS [5]. T-MACS was derived by logistic regression,
using details of a patient's symptoms with electrocardio-
graphic (ECG) findings and cardiac troponin (cTn) con-
centrations, measured on arrival at ED, to calculate the
probability that a patient has ACS. T-MACS classified
patients with <2% probability of ACS as being 'very low
risk', in this population this strategy identified 40% of
patients as eligible for safe, immediate discharge from
the ED [5].
T-MACS has been externally validated in 1,459 pa-
tients from three prospective studies in the United King-
dom [5], 1,244 patients from Australasia [6], and multi-
centre prospective trials from the United Kingdom [7],
Thailand [8] and Norway [9], each of which demon-
strated acceptable predictive performance. A pilot ran-
domized controlled trial of a precursor version of the
algorithm showed that its use led to significantly more
safe discharges from the ED within 4 hours of arrival
than standard care [10]. The data from UK studies
(which did not rely on the use of surrogate variables)
consistently show that over 40% of patients are cate-
gorised as very low risk and can have ACS ‘ruled out’
with one blood test. It has been shown to safely reduce
unnecessary hospital admissions, outperforming the al-
gorithms currently advocated in NICE guidelines [2, 11].
Countering calibration drift
However, the performance (calibration and discrimin-
ation) of many clinical prediction models, such as T-
MACS, is likely to decline with time [12, 13]. For ex-
ample, this has been demonstrated previously with the
EuroScore model that predicts short-term mortality after
cardiac surgery [14]. Therefore, the same phenomenon
is likely to occur with the T-MACS algorithm as patient
demographics change and diagnostic technology evolves.
Indeed, the very fact that T-MACS is implemented in
practice can lead to it losing diagnostic performance,
since the implementation of the model changes the
predictor-outcome associations and the case-mix, mean-
ing that the performance of the model degrades over
time [15, 16].
In part, the above issues with “calibration drift” can be
attributed to the fact the algorithm itself is static, having
been derived in one sample over a fixed time-period. It
is unlikely to be the optimal algorithm for early diagno-
sis in various locations with diverse populations, due to
the population and, possibly, intervention heterogeneity.
This has been attempted previously with the EuroScore,
which was shown to demonstrate calibration drift due to
changing demographics [14]. Siregar et al investigated
the merits of various methods through which to update
such models [17]. They found many had a similar im-
provement on the clinical prediction models (regression
co-efficient updating and dynamic updating).
Model updating and dynamic approaches to clinical
prediction models
Statistical methods have previously been proposed to
overcome issues such as calibration drift, by allowing pre-
diction models to be re-derived and validated to maintain
their predictive performance through time [18]. Such cy-
cles of learning allow the models to account for demo-
graphic shifts and changes in diagnostic technology. This
has several advantages over continuously re-developing
the model de novo, as model updating utilises existing evi-
dence (current versions of the model) and can potentially
be delivered in almost real-time. Specifically, several differ-
ent methods for updating clinical prediction models have
been suggested [12, 18]; including regression coefficient
updating, meta-model updating and dynamic updating.
Regression coefficient updating only modifies individual
coefficients within the model from a singular further ana-
lysis. Bayesian dynamic updating allows for continuous
updating and derivation, once the method has been evalu-
ated it can theoretically continuously re-derive with new
data [19, 20]. Siregar et al’s analysis of dynamic updating
suggested that a Bayesian approach may yield greater im-
provements in accuracy, when the sample is small [17].
Strobl et al [21] demonstrated that in updating prostate
cancer risk assessment tools, there were also multiple
methods that yielded similar improvement, with the ex-
ception of Random Forest regression (a machine learning
form of dynamic updating) which was substantially worse
than others.
In summary, T-MACS requires protection against cali-
bration drift, and as such we aim to utilise prediction
model updating methods to recalibrate it through time.
Here, we describe the protocol for the study that will
deliver these objectives, in full accordance with the
Transparent Reporting of the Predictive accuracy of a
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multivariable prediction model for Individual Prognosis
Or Diagnosis (TRIPOD) guidelines [22].
Methods
Study arm design and study setting
This will be a multi-centre retrospective cohort study.
The study will use data collected from emergency de-
partments at Manchester Royal Infirmary (MRI), Royal
Blackburn Teaching Hospital (RBTH) and Burnley Gen-
eral Teaching Hospital (BGTH). MRI is a major trauma
centre with 1,721 beds and an emergency department at-
tendance of 104,449 in 2020, RBTH has 700 inpatient
beds with an emergency department attendance of
104,009 in 2020 and BGTH has 219 beds and its urgent
care centre has an annual attendance of 44,519. Each of
these hospitals has implemented TMACS to guide the
care of patients with suspected ACS.
Study population
We will include patients who presented to the emer-
gency department with chest pain and were assessed
using the TMACS pathway since implementation at
MRI, RBTH and BGTH. This is estimated to include ap-
proximately 14,000 patient episodes from June 2016 to
October 2020.
Sample Size
We utilised the sample size calculation described by
Riley et al [23] and also the rule of 10 primary outcome
cases by variable used in similar logistic regression ana-
lyses. TMACS includes seven variables. As it is also
planned to incorporate time, geographical location and
the outcome of two alternative clinical prediction
models (adding 8 variables), it is anticipated that the
analysis will require a minimum of 170 cases in the
training/optimization set. The prevalence of the primary
outcome is 6.9% in the first 1,033 patients treated with
TMACS. Based on that prevalence, a minimum of 2,464
patients would be required. This sample size was larger
than that calculated by Riley et al, so we opted to be
conservative and use the higher initial calculation [23].
Data Collection
This cohort will include patients who received routine
care guided by TMACS, and whose data have been saved
using bespoke interfaces deployed at Manchester Royal
Infirmary (MRI), Royal Blackburn Teaching Hospital
(RBTH) and Burnley General Teaching Hospital
(BGTH). These tools are used in clinical practice and
prospectively capture the data inputted by clinicians.
This will be collated with data from local hospital
servers to include: serial troponin assay results, and local
diagnostic codes. This data will be cross-referenced with
NHS Digital’s Hospital Episode Statistics (HES) database
to include any diagnosis or intervention that occurs
within 30 days of the index presentation. We will also
link with the civil registry database for mortality
outcomes.
Data Validation
Assuring the quality of the data is vital for the integrity
of this study, particularly as we are collating multiple da-
tabases across multiple organisations. We will use the
principles laid out by Weiskopf et al to assure the quality
of the data [24] (see Table 1).
Outcome Variables
The primary outcome will be acute myocardial infarc-
tion (AMI) within 30 days. Patients will be considered
to have a diagnosis of AMI if they have either a
coded clinical diagnosis of AMI locally or held cen-
trally with NHS Digital. Only primary ICD-10 codes
will be used for the outcome, however a sensitivity
analysis will be conducted where a code at any pos-
ition is used. The relevant ICD-10 codes are: I21, I22,
or I23 [25].. A secondary composite outcome of
major adverse cardiovascular events within 30 days
will also be measured including acute myocardial in-
farction, death (as per civil registry) and revascularisa-
tion. ICD-10 outcomes include I21, I22, I23, I46, R96,
R99, K40-50, K63, and K75
The use of coded diagnoses is essential for the process
to be automated in future. However, the effect of accept-
ing these definitions must be carefully considered due to
concerns over the limitations of the coding databases
both centrally and locally. This will be explored by con-
ducting data validation and the effect of the differing
outcomes will be examined in sensitivity analyses. We
will blind the adjudicators to the TMACS inputs and
prediction.
In data validation we will examine the local coded
diagnoses of any patients who had at least one car-
diac concentration above the 99th percentile upper
reference limit for the assay and an absolute change
of at least half the 99th percentile on serial sampling
(for samples drawn 3-6 hours apart). We will not
examine patients with two (adequately timed) tropo-
nin concentrations within the normal range as they
cannot fulfil the diagnosis of AMI. We will adjudicate
outcomes by a central committee. AMI will be de-
fined in accordance with the universal definition of
myocardial infarction, which requires a rise and/or fall
of cardiac troponin with at least one concentration
above the 99th percentile upper reference limit of the
assay. In addition, patients must have at least one of:
symptoms compatible with myocardial ischaemia,
ECG changes compatible with ischaemia, imaging evi-
dence of new loss of viable myocardium or
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identification of intracoronary thrombus at coronary
angiography. In the GM-TMACS project, initial im-
plementation of TMACS will require all patients to
have two cardiac troponin tests drawn 3 hours apart.
Thus, all patients included in the analyses presented
here will have an acceptable reference standard for
the diagnosis of AMI according to national and inter-
national guidelines [2, 26]. Diagnoses will be adjudi-
cated by two independent investigators with reference
to all relevant clinical investigations. Disagreements
will be resolved by consulting with a third independ-
ent investigator.
Analysis
The methodology optimising predictive performance
for updating the TMACS algorithm will be identified
from four candidate types. Predictive performance will
be assessed by calibration plots, Brier scores, discrim-
ination will be assessed with the c-statistic compared
with DeLong’s method [27]. We will examine con-
tinuation of the current model (status quo), model re-
calibration, model revision, and Bayesian dynamic
modelling [13, 18]. TMACS currently returns a prob-
ability of ACS, which is then used to classify patients
into a categorical risk group (Eq 1 ). We will examine
the re-classification of patients from the original
TMACS algorithm and the dynamic modelling





¼ 1:713xe þ 0:847xa þ 0:607xr
þ 1:417xv þ 2:058xs þ 1:208xh
þ 0:089xt−4:766 ð1Þ
Equation [1] - The TMACS clinical prediction model.
l = log-odds of the primary outcome acute myocardial
infarction, xe = presence of ECG ischaemia, xa = cres-
cendo angina, xr = paint radiating to the right arm, xv=
pain associated with vomiting, xs = sweating observed,
xh= hypotension, and xt = is high sensitivity troponin T
result on arrival.
Status Quo
The current iteration of the TMACS algorithm will be
validated with the existing co-efficient and intercept
(from the derivation study). This will serve as a baseline
for comparison, and we will use it to assess for evidence
of change of discrimination and calibration over time
(Eq 2).




Equation 2: The current iteration of the TMACS algo-
rithm, where Zsq - the linear prediction of the current
model, αTMACS - intercept and βi, TMACS previously de-
rived regression coefficients.
Table 1 Data validation procedures adapted from Weiskopf et al [24]
Data Assessment Method Data Quality Dimension Databases Data points
Gold Standard Comparison Completeness & correctness intra-EPR laboratory results
intra-EPR personal identifiers
intra-EPR dates of events
Data element agreement Completeness, correctness, concordance intra-EPR physiological parameters
intra-EPR dates of events
Element presence Completeness NHSD & EPR All data points
Data source agreement Completeness, concordance, plausibility NHSD vs EPR ICD-10 codesb
NHSD vs EPR dates of events
EPR & paper records CPM parametersa
Distribution comparison Completeness, concordance, plausibility EPR Demographic data
EPR CPM covariates
NHSD & EPR outcome data
Validity check Correctness and plausibility intra-EPR Demographic data
intra-EPR CPM covariate data
Log review Correctness and currency intra-EPR CPM entry date
NHSD episode entry date
EPR – local electronic patient record, NHSD – National Health Service Digital (UK), CPM – clinical prediction model, ICD-10 – international classification of disease
version 10. a this is detailed in the supplementary appendix b a sensitivity analysis is also planned, see the outcome variable subsection
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Model recalibration
In this method we will recalibrate the TMACS algorithm
with the entire dataset and apply an overall weight to
the original algorithm and derive a new intercept, this is
described in Eq. 3 [29]. This has been included as it is
the simplest and has been used previously to updated
CPMs [30].
Zmr ¼ α̂þ β̂oZsq





Equation 3: Zmr - model updated by recalibration, α̂ is
the re-estimated intercept, bβo the new overall calibration
slope, and Zsq – is the linear prediction of the TMACS
model.
Model extension
Additional variables will be considered for incorporation
from other clinical prediction models that have been
used for the same purpose (Eq. 4). These include predic-
tors from the HEART score and Thrombolysis in Myo-
cardial Infarction (TIMI) risk score [29, 30]. We will re-
derive the algorithm with these covariates to investigate







β̂ jx j ð4Þ
Equation 4: Ze - model updated by extension, βi are
the original coefficients for the original covariables, s is
the new covariates and β̂i their new coefficients.
Bayesian dynamic updating
Dynamic updating allows the original model’s intercepts
and co-efficients to be updated after each patient epi-
sode, stabilising calibration and improving performance
[12, 20]. This will be deployed incorporating guidance
from our patient and public representatives. The repre-
sentatives stated that if such a method were used then
they felt that it initially ought to require human over-
sight. As such the initial updating will not be after each
recorded patient episode instead it will be every three
months for the first year to simulate a probationary
period with quarterly meetings. After this period we will
update the model after every patient episode. This is
achieved through recursive estimation using the predic-
tion equation
βt j Y t−1  N β̂t−1;Rt
 
Where β is a dimensional vector of regression coeffi-






. λt is known as the forgetting fac-
tor, which down-weights past observations by inflating
the variance, and will be chosen in order to enable the
sample size to continue to meet the specifications laid
out by Riley et al [23].
When this is then taken into a Bayesian framework,
the posterior is proportional to the product of the prob-




 p βt jY t−1 ∝likelihood x prior
Validation
Model recalibration and model revision methods will be
internally validated by using a bootstrap validation of
1000 samples. The dynamic updating methodologies will
be internally validated with one-step a head prequential
testing [13].
Ethics and dissemination:
This study has received ethical approval from a research
ethics committee and the confidentiality advisory group
(references 19/WA/0311, and 19/CAG/0209).
The study is registered on the ISRCTN number: ISRC
TN41008456
First, we aim to publish our findings in peer reviewed
journals. The primary target audience for the clinical
study will be emergency medicine physicians, acute
medicine physicians, cardiologists, clinical biochemists,
public health professionals and industry leaders in acute
diagnostics.
Further we will aim to present our findings at inter-
national and national conferences with relevant target
audiences (e.g. European Society for Emergency Medi-
cine Annual Congress, European Society of Cardiology
Annual Conference, Royal College of Emergency Medi-
cine Annual Scientific Conference). In addition, we will
develop a public engagement strategy in conjunction
with Public Programmes and our patient groups, in
order that the local population have the opportunity to
learn about our work and to engage with future work.
Discussion
We aim to recalibrate TMACS protecting the research
investment of time and money, but potentially also im-
proving it’s clinically efficacy. However, this method
could be applied to any clinical prediction model, a
plethora of which are deployed within emergency medi-
cine. These range from the Well’s score for deep vein
thrombosis to the Ottawa ankle score for fractures [31,
32]. These were all derived and then externally validated,
but subsequently their upkeep stopped.
The recent focus of research has been the develop-
ment and deployment of new clinical prediction models.
Here we present a method that follows the paradigm
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shift in the focus of modelling research. The scientific
community must adapt to an overly saturated environ-
ment of clinical prediction models [33, 34], part of the
answer is assessing what already exists and seeking to
protect and improve it . Not only is this an efficiency
but it also recalibrates the community of clinical mod-
elers to follow one of the central thesis of science, to
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